The HIV care cascade in sub‐Saharan Africa: systematic review of published criteria and definitions
C Mugglin, D Kläger, A Gueler… - African Journal of …, 2021 - journals.lww.com
2 METHODS We examined guidance on systematic reviews of observational studies [9, 10]
when planning this review and report our review according to the PRISMA statement [11] …
when planning this review and report our review according to the PRISMA statement [11] …
[PDF][PDF] Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives.
JC Yombi, H Mertes - AIDS reviews, 2018 - dial.uclouvain.be
Abstract In 2008, the Swiss National AIDS Commission issued a statement about the safety
of HIV treatment in terms of reduced transmission in serodiscordant couples to reduce …
of HIV treatment in terms of reduced transmission in serodiscordant couples to reduce …
Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV
Antiretroviral therapy (ART) has dramatically lengthened lifespan among people with HIV
(PWH), but this population experiences heightened rates of inflammation-related …
(PWH), but this population experiences heightened rates of inflammation-related …
[HTML][HTML] Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries
P de Los Rios, C Okoli, Y Punekar, B Allan… - Preventive …, 2020 - Elsevier
Modern antiretroviral therapy (ART) has improved the lives of people living with HIV (PLHIV)
but currently requires daily adherence. We assessed prevalence and correlates of …
but currently requires daily adherence. We assessed prevalence and correlates of …
The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030
E Ndashimye, EJ Arts - Infectious Diseases of Poverty, 2019 - mednexus.org
Background: Over 90% of Human Immunodeficiency Virus (HIV) infected individuals will be
on treatment by 2020under UNAIDS 90-90-90 global targets. Under World Health …
on treatment by 2020under UNAIDS 90-90-90 global targets. Under World Health …
Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries
B Akinwunmi, D Buchenberger, J Scherzer… - Sexually transmitted …, 2021 - sti.bmj.com
Objectives A novel long-acting regimen (LAR) of cabotegravir and rilpivirine for HIV
treatment requires dosing every 2 months instead of daily. We assessed what proportion of …
treatment requires dosing every 2 months instead of daily. We assessed what proportion of …
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
F Bonnet, F Le Marec, O Leleux, Y Gerard… - BMC Infectious …, 2020 - Springer
Background The objective of the study was to describe the evolution of chronic non-AIDS
related diseases and their risk factors, in patients living with HIV (PLHIV) in the French …
related diseases and their risk factors, in patients living with HIV (PLHIV) in the French …
Human immunodeficiency virus continuum of care in 11 European Union countries at the end of 2016 overall and by key population: have we made progress?
Background High uptake of antiretroviral treatment (ART) is essential to reduce human
immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care …
immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care …
Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017
C Iniesta, D Álvarez-del Arco, LM García-Sousa… - PLoS …, 2018 - journals.plos.org
Objective To assess the awareness, knowledge, use, and willingness to use and need of
PrEP among men who have sex with men (MSM) and transgender women (TW) who …
PrEP among men who have sex with men (MSM) and transgender women (TW) who …
Substantial heterogeneity in progress toward reaching the 90-90-90 HIV target in the WHO European region
K Porter, A Gourlay, K Attawell, D Hales… - JAIDS Journal of …, 2018 - journals.lww.com
Background: Achieving the UNAIDS 90-90-90 target by 2020 is expected to end the HIV
epidemic by 2030. We report on progress in the WHO European Region in meeting this …
epidemic by 2030. We report on progress in the WHO European Region in meeting this …